Upexi, Inc. (NASDAQ:UPXI – Get Free Report) CFO Andrew James Norstrud acquired 43,860 shares of the stock in a transaction on Thursday, April 17th. The shares were acquired at an average price of $2.28 per share, with a total value of $100,000.80. Following the purchase, the chief financial officer now owns 59,138 shares in the company, valued at $134,834.64. This represents a 287.08 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Upexi Price Performance
Upexi stock opened at $15.51 on Friday. Upexi, Inc. has a 52 week low of $1.90 and a 52 week high of $22.57. The company has a current ratio of 0.58, a quick ratio of 0.53 and a debt-to-equity ratio of 0.35. The stock has a 50 day moving average of $3.51 and a 200-day moving average of $4.12.
Upexi (NASDAQ:UPXI – Get Free Report) last posted its quarterly earnings data on Friday, February 14th. The company reported ($1.24) EPS for the quarter. The business had revenue of $4.01 million for the quarter.
Hedge Funds Weigh In On Upexi
About Upexi
Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.
Read More
- Five stocks we like better than Upexi
- 3 Best Fintech Stocks for a Portfolio Boost
- Markets Think Robinhood Earnings Could Send the Stock Up
- How to Use the MarketBeat Excel Dividend Calculator
- Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains?
- What is the Euro STOXX 50 Index?
- AT&T: Subscriber Growth & Buybacks Signal Bullish Turnaround
Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.